|
RNF216L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.87940005172516E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18039999996711E-07 |
| Normal-vs-Stage2 |
5.524900E-03 |
| Normal-vs-Stage3 |
1.349860E-02 |
| Normal-vs-Stage4 |
2.618300E-03 |
| Stage1-vs-Stage2 |
6.760000E-01 |
| Stage1-vs-Stage3 |
3.375600E-01 |
| Stage1-vs-Stage4 |
8.030000E-01 |
| Stage2-vs-Stage3 |
3.023400E-01 |
| Stage2-vs-Stage4 |
6.291600E-01 |
| Stage3-vs-Stage4 |
6.954800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.12319994918886E-09 |
| Normal-vs-AfricanAmerican |
5.78809999999264E-05 |
| Normal-vs-Asian |
2.620800E-01 |
| Caucasian-vs-AfricanAmerican |
4.034400E-01 |
| Caucasian-vs-Asian |
6.403000E-01 |
| AfricanAmerican-vs-Asian |
8.586800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07049999975573E-08 |
| Normal-vs-Female |
2.62120000038557E-07 |
| Male-vs-Female |
6.063200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.370300E-04 |
| Normal-vs-Extreme_Weight |
2.33990000042539E-07 |
| Normal-vs-Obese |
2.16339999999926E-05 |
| Normal-vs-Extreme_Obese |
4.142200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.228400E-01 |
| Normal_Weight-vs-Obese |
7.485600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.026600E-01 |
| Extreme_Weight-vs-Obese |
2.660200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.413000E-01 |
| Obese-vs-Extreme_Obese |
7.074800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.90540000000383E-05 |
| Normal-vs-Age(41-60Yrs) |
4.43209913214559E-11 |
| Normal-vs-Age(61-80Yrs) |
1.90639999997355E-06 |
| Normal-vs-Age(81-100Yrs) |
6.401600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.117400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.685400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.329800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.838000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.961600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.073210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.84363635469253E-12 |
| Normal-VS-Type2 PRCC |
1.496800E-01 |
| Normal-VS-KIRP CIMP |
3.613300E-04 |
| Normal-VS-Unclassified PRCC |
8.621600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.8878000274114E-09 |
| Type1 PRCC-VS-KIRP CIMP |
4.563000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.104000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.166400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.801200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.338800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.217200E-03 |
| Normal-vs-N1 |
5.625700E-04 |
| Normal-vs-N2 |
1.044540E-03 |
| N0-vs-N1 |
1.431580E-01 |
| N0-vs-N2 |
1.996800E-01 |
| N1-vs-N2 |
6.133000E-01 |
|
|
